$36.7 Billion Worldwide Diabetes Devices Industry to 2027

September 16, 2020

“Diabetes Devices – Global Market Trajectory & Analytics”: Research and Markets bring years of research experience to the 6th edition of this report. The 180-page report presents concise insights into how the pandemic has impacted production and the buy-side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Global Diabetes Devices Market to Reach $36.7 Billion by 2027

Amid the COVID-19 crisis, the global market for Diabetes Devices estimated at US$24.7 Billion in the year 2020, is projected to reach a revised size of US$36.7 Billion by 2027, growing at a CAGR of 5.8% over the period 2020-2027.

Monitoring and Diagnostic Devices, one of the segments analyzed in the report, is projected to record 5.8% CAGR and reach US$26.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Insulin Delivery Devices segment is readjusted to a revised 6% CAGR for the next 7-year period.

The U.S. Market is Estimated at $6.7 Billion, While China is Forecast to Grow at 8.9% CAGR

The Diabetes Devices market in the U.S. is estimated at US$6.7 Billion in the year 2020. China, the world`s second-largest economy, is forecast to reach a projected market size of US$7.8 Billion by the year 2027 trailing a CAGR of 8.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.2% and 5.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Competitors identified in this market include, among others:

  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Medtronic PLC
  • Novo Nordisk A/S
  • Sanofi SA

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Diabetes Devices Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

  • Total Companies Profiled: 42

Additional information can be found here.

Hot this week

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMedâ„¢ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.